Laxmi Dental (LAXMIDENTL)

FairStock Score: 27/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹194.10, Laxmi Dental asks me to pay ₹1,058 crore for a business whose latest quarter produced just ₹2 crore in net profit. That arithmetic does not excite me. Graham taught me to invest on facts, not on hopes. The balance sheet is clean: debt/equity of 0.04 and ROCE of 19.20% show sensible capital deployment. A Piotroski score of 7/9 also tells me the financial position is not deteriorating. But the price-to-earnings ratio stands at 39.45 while sales grew only 7.09%. The 22.29% profit growth looks nice, but it starts from a small base; the latest quarter's net margin is barely 3%. I cannot call that a durable moat. Dental supplies may be a decent niche, but with promoter holding at 41.70%, outside shareholders depend on insiders, and with zero dividend, the only return is price appreciation. Mr. Market has been emotional, swinging from ₹382.75 to ₹155.88 in a year, and now ₹194.10 still gives me no margin of safety. The PEG ratio of 2.69 says I am paying almost three times the earnings growth rate. FairStock scores it 21 out of 100, and I agree with the warning. If I were buying the whole company privately, would I pay 39 times earnings for a business growing sales at 7%? No. I would wait. Let earnings catch up to the price, or better, let the price fall to a level where the downside is limited. A clean balance sheet is good, but a good business at a fair price is not enough; I want a wonderful business at an attractive price. Today Laxmi Dental is neither clear enough nor cheap enough for my circle of competence.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer